Related Experiment Videos
House dust mite asthma. Correlation between allergen sensitivity in various organs
Allergy
|August 1, 1987
Summary
House dust mite allergy testing in asthmatics shows varying organ sensitivities. Pulmonary allergen sensitivity correlates with histamine release and bronchial reactivity, suggesting potential diagnostic alternatives.
Area of Science:
- Allergy and Immunology
- Pulmonology
- Clinical Diagnostics
Background:
- House dust mite (Dermatophagoides pteronyssinus, Dp) allergy is a common trigger for asthma.
- Hyposensitization is a treatment option for allergic asthma.
- Evaluating organ-specific sensitivity to allergens is crucial for accurate diagnosis.
Purpose of the Study:
- To assess the correlation between Dermatophagoides pteronyssinus (Dp) allergen sensitivity in different organs of asthmatic patients.
- To investigate the relationship between pulmonary allergen sensitivity and other allergy markers.
- To explore potential alternative diagnostic methods for bronchial allergen challenge.
Main Methods:
- Fifty asthmatics underwent bronchial, nasal, and conjunctival challenges with Dp, alongside histamine challenges.
- Skin prick tests (SPT), histamine release (HR) from blood cells, and serum anti-Dp-IgE (RAST) were performed.
- Analysis focused on 40 patients with positive reactions across all tests.
Main Results:
- Organ-specific sensitivity to Dp did not consistently parallel across individuals.
- A significant correlation was found between pulmonary allergen sensitivity and HR (r=0.65) and histamine sensitivity (r=0.47).
- Combined HR and non-specific bronchial reactivity explained 53% of bronchial allergen sensitivity variation; RAST and SPT showed weaker correlations.
Conclusions:
- Bronchial allergen challenge cannot be substituted by challenges in other organs due to unrelated mucosal sensitivities.
- Diagnosis should target the organ with primary clinical importance.
- Measuring non-specific bronchial reactivity and cellular allergen sensitivity may offer an alternative to direct bronchial allergen challenge, avoiding adverse reactions.